Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering Biomaterial-Drug Conjugates for Local and Sustained Chemotherapeutic Delivery.

Bioconjugate chemistry·2015
Same author

A bioreactor system for in vitro tendon differentiation and tendon tissue engineering.

Journal of orthopaedic research : official publication of the Orthopaedic Research Society·2015
Same author

A silk-based encapsulation platform for pancreatic islet transplantation improves islet function in vivo.

Journal of tissue engineering and regenerative medicine·2015
Same author

Silk hydrogels for sustained ocular delivery of anti-vascular endothelial growth factor (anti-VEGF) therapeutics.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2015
Same author

Silk macromolecules with amino acid-poly(ethylene glycol) grafts for controlling layer-by-layer encapsulation and aggregation of recombinant bacterial cells.

ACS nano·2015
Same author

Biomineralization of stable and monodisperse vaterite microspheres using silk nanoparticles.

ACS applied materials & interfaces·2015

Related Experiment Video

Updated: Jun 3, 2026

Nanofibrillar Basement Membrane Mimic Made of Recombinant Functionalized Spider Silk in Custom-Made Tissue Culture Inserts
06:17

Nanofibrillar Basement Membrane Mimic Made of Recombinant Functionalized Spider Silk in Custom-Made Tissue Culture Inserts

Published on: November 1, 2024

Antimicrobial functionalized genetically engineered spider silk.

Sílvia C Gomes1, Isabel B Leonor, João F Mano

  • 13B's Research Group - Biomaterials, Biodegradables and Biomimetics, Department of Polymer Engineering, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Zona Indústrial da Gandra, 4806-909 Caldas das Taipas, Guimarães, Portugal.

Biomaterials
|April 5, 2011
PubMed
Summary
This summary is machine-generated.

Engineered spider silk fusion proteins show antimicrobial activity against bacteria. These biomaterials self-assemble and are compatible with human cells, offering potential for medical applications.

More Related Videos

Synthetic Spider Silk Production on a Laboratory Scale
13:36

Synthetic Spider Silk Production on a Laboratory Scale

Published on: July 18, 2012

Related Experiment Videos

Last Updated: Jun 3, 2026

Nanofibrillar Basement Membrane Mimic Made of Recombinant Functionalized Spider Silk in Custom-Made Tissue Culture Inserts
06:17

Nanofibrillar Basement Membrane Mimic Made of Recombinant Functionalized Spider Silk in Custom-Made Tissue Culture Inserts

Published on: November 1, 2024

Synthetic Spider Silk Production on a Laboratory Scale
13:36

Synthetic Spider Silk Production on a Laboratory Scale

Published on: July 18, 2012

Area of Science:

  • Biomaterials Science
  • Protein Engineering
  • Synthetic Biology

Background:

  • Genetically engineered fusion proteins are promising multifunctional biomaterials.
  • Recombinant DNA technology enables combining diverse protein functionalities.
  • Spider silk's self-assembly properties are valuable for biomaterial design.

Purpose of the Study:

  • To design, clone, express, and functionalize novel fusion proteins.
  • To combine spider silk with human antimicrobial peptides (HNP-2, HNP-4, hepcidin).
  • To evaluate the antimicrobial and biocompatibility properties of these new biomaterials.

Main Methods:

  • Recombinant DNA technology for protein fusion.
  • Antimicrobial assays against Escherichia coli and Staphylococcus aureus.
  • Dynamic light scattering for aggregation analysis.
  • Spectroscopic methods (ATR-FTIR, CD) for secondary structure determination.
  • In vitro cell studies using SaOs-2 cell line.

Main Results:

  • Successful design, cloning, and expression of three fusion proteins.
  • Demonstrated antimicrobial activity against Gram-negative and Gram-positive bacteria.
  • Spider silk domain retained self-assembly into beta-sheets without chemical cross-linking.
  • Protein aggregation patterns were clarified using dynamic light scattering.
  • Secondary structure analysis confirmed protein integrity.
  • In vitro studies showed compatibility with mammalian cells.

Conclusions:

  • The novel silk-based fusion proteins exhibit potent antimicrobial activity.
  • These biomaterials possess inherent self-assembly capabilities and are biocompatible.
  • The engineered proteins represent a new class of multifunctional polymeric biomaterials for potential medical use.